Armata Pharmaceuticals In... (ARMP)
1.50
-0.08 (-5.06%)
At close: Mar 31, 2025, 3:59 PM
1.41
-6.00%
After-hours: Mar 31, 2025, 05:26 PM EDT
-5.06% (1D)
| Bid | 1.37 |
| Market Cap | 54.27M |
| Revenue (ttm) | 966K |
| Net Income (ttm) | -18.92M |
| EPS (ttm) | -0.89 |
| PE Ratio (ttm) | -1.69 |
| Forward PE | -1.23 |
| Analyst | Buy |
| Ask | 1.63 |
| Volume | 46,704 |
| Avg. Volume (20D) | 11,937 |
| Open | 1.60 |
| Previous Close | 1.58 |
| Day's Range | 1.34 - 1.67 |
| 52-Week Range | 1.34 - 4.25 |
| Beta | 0.90 |
About ARMP
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It h...
Industry Biotechnology
Sector Healthcare
IPO Date May 20, 1994
Employees 60
Stock Exchange AMEX
Ticker Symbol ARMP
Website https://www.armatapharma.com
Analyst Forecast
According to 1 analyst ratings, the average rating for ARMP stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 366.67% from the latest price.
Stock ForecastsNext Earnings Release
Armata Pharmaceuticals Inc. is scheduled to release its earnings on Apr 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
